The first line of treatment for RRMS is consisted of interferon beta (IFN-β) and is glatiramer acetate.3 They have a good effect on reducing relapse and a variety of disabilities and on magnetic resonance imaging (MRI) criteria. Here, IFNB1 is linked to relapsing-remitting multiple sclerosis.